Efficacy and safety of efgartigimod PH20 SC for Sjögren's disease-associated dryness: study protocol for an investigator-initiated, multicenter, phase 2, randomized, double-blind, placebo-controlled trial (OASIS study)
efgartigimod PH20 SC 治疗干燥症相关干燥症状的疗效和安全性：一项研究者发起的多中心 2 期随机双盲安慰剂对照试验的研究方案（OASIS 研究）
期刊:Frontiers in Medicine
影响因子:3
doi:10.3389/fmed.2025.1719757
Endo, Yushiro; Hosogaya, Naoki; Fukushige, Yuri; Narita, Sawana; Jacobs, Julie; Reiss, William; Imai, Yuya; Shimizu, Toshimasa; Koga, Tomohiro; Yamamoto, Hiroshi; Sakai, Tomoya; Takagi, Yukinori; Sumi, Misa; Kawakami, Atsushi
